https://hpass.tv/capitolo/malattie-mieloproliferative-croniche/https://hpass.tv/capitolo/classificazione-who-delle-malattie-mieloproliferative-croniche/https://hpass.tv/capitolo/sindromi-mielodisplastiche/https://hpass.tv/capitolo/highlights/https://hpass.tv/capitolo/hematology-passport-e-eha/https://hpass.tv/capitolo/classificazione-who-sindromi-mielodisplastiche/https://hpass.tv/capitolo/ruolo-del-trapianto-oggi/https://hpass.tv/capitolo/leucemia-mielomonocitica-cronica/https://hpass.tv/capitolo/leucemie-acute-linfoidi/https://hpass.tv/capitolo/dirodini-linfoproliferativi-cronici/https://hpass.tv/capitolo/linfomi/https://hpass.tv/capitolo/patologie-del-globulo-rosso/https://hpass.tv/capitolo/specials/https://hpass.tv/capitolo/leucemia-linfatica-cronica/https://hpass.tv/capitolo/il-ruolo-del-laboratorio-oggi-nella-diagnostica-differenziale-delle-malattie-linfoproliferative-croniche/https://hpass.tv/capitolo/leucemia-linfatica-cronica-patogenesi-e-fattori-predittivi/https://hpass.tv/capitolo/leucemia-linfatica-cronica-terapia-del-paziente-recidivato-refrattario/https://hpass.tv/capitolo/linfomi-a-cellule-b/https://hpass.tv/capitolo/patogenesi-dei-linfomi-a-cellule-b-diffuso-a-grandi-cellule-mantellare-e-follicolare/https://hpass.tv/capitolo/linfoma-diffuso-a-grandi-cellule-terapia/https://hpass.tv/capitolo/linfoma-mantellare-terapia/https://hpass.tv/capitolo/linfoma-follicolare-terapia/https://hpass.tv/capitolo/linfoma-di-hodgkin/https://hpass.tv/capitolo/linfoma-di-hodgkin-patogenesi/https://hpass.tv/capitolo/linfoma-di-hodgkin-terapia-di-prima-linea-e-di-salvataggio/https://hpass.tv/capitolo/mieloma/https://hpass.tv/capitolo/mieloma-multiplo-patogenesi/https://hpass.tv/capitolo/amiloidosi/https://hpass.tv/capitolo/leucemia-a-plasmacellule/https://hpass.tv/capitolo/emostasi-e-trombosi/https://hpass.tv/capitolo/leucemie-acute-linfoblastiche/https://hpass.tv/capitolo/leucemie-acute-mieloidi-lam/https://hpass.tv/capitolo/anticorpi-monoclonali-e-target-therapy-nelle-lam/https://hpass.tv/capitolo/leucemia-acuta-promielocitica-diagnosi-complicanze-e-terapia/https://hpass.tv/capitolo/le-leucemie-secondarie/https://hpass.tv/capitolo/eha-educational-program/https://hpass.tv/capitolo/european-hematology-exam/https://hpass.tv/capitolo/mieloma-highlights/https://hpass.tv/capitolo/leucemia-linfatica-cronica-highlights/https://hpass.tv/capitolo/terapia-antitrombotica/https://hpass.tv/capitolo/terapia-dell-emofilia/https://hpass.tv/capitolo/car-t-cells-2/https://hpass.tv/capitolo/anemie/https://hpass.tv/capitolo/metabolismo-del-ferro-e-anemia-nello-stato-infiammatorio/https://hpass.tv/capitolo/anemie-carenziali/https://hpass.tv/capitolo/difetti-di-membrana-ed-enzimopenie/https://hpass.tv/capitolo/le-sindromi-talassemiche/https://hpass.tv/capitolo/anemia-falciforme/https://hpass.tv/capitolo/sindrome-emolitico-uremica/https://hpass.tv/capitolo/emoglobinuria-parossistica-notturna/https://hpass.tv/capitolo/anemia-aplastica-e-prca/https://hpass.tv/capitolo/emocromatosi-ed-iperferritinemie/https://hpass.tv/capitolo/avanzamenti-nei-disordini-linfoproliferativi-cronici/https://hpass.tv/capitolo/avanzamenti-sulluso-delle-car-t-nelle-leucemie-mieloma-linfomi/https://hpass.tv/capitolo/eha-session/https://hpass.tv/capitolo/leucemie-acute-mieloidi/https://hpass.tv/capitolo/leucemia-mieloide-cronica/https://hpass.tv/capitolo/malattie-mieloproliferative-croniche-ph/https://hpass.tv/capitolo/mielodisplasie/https://hpass.tv/capitolo/citogenetica-fish/https://hpass.tv/capitolo/mieloproliferativi-cronici/https://hpass.tv/capitolo/leucemie-linfatiche-croniche-llc/https://hpass.tv/capitolo/emostasi-e-trombosi-2/https://hpass.tv/capitolo/trombocitopenia-in-gravidanza/https://hpass.tv/capitolo/leucemie-acute-linfoblastiche-lal-2/https://hpass.tv/capitolo/terapie-domiciliari-terapie-palliative-end-of-life/https://hpass.tv/capitolo/farmaci-oppioidi-nel-dolore-neoplastico-elementi-essenziali/https://hpass.tv/capitolo/cure-domiciliari-ematologiche-e-gestione-dei-sintomi-refrattari/https://hpass.tv/capitolo/complicanze-infettive-in-ematologia/https://hpass.tv/capitolo/aggiornamento-in-tema-di-epidemiologia-del-rischio-infettivo-nei-pazienti-ematologici-alla-luce-delle-recenti-evoluzioni-terapeutiche/https://hpass.tv/capitolo/la-diagnosi-microbiologica/https://hpass.tv/capitolo/farmacologia-clinica-degli-antimicrobici-nel-paziente-ematologico/https://hpass.tv/capitolo/gestione-diagnostico-terapeutica-della-neutropenia-febbrile/https://hpass.tv/capitolo/metodologia-della-sperimentazione-clinica/https://hpass.tv/capitolo/introduzione/https://hpass.tv/capitolo/tipologia-degli-studi-clinici/https://hpass.tv/capitolo/dalla-domanda-di-ricerca-allarticolo-pubblicato/https://hpass.tv/capitolo/dal-trial-tradizionale-al-trial-decentralizzato/https://hpass.tv/capitolo/trapianto-di-cellule-staminali-emopoietiche-cse/https://hpass.tv/capitolo/introduzione-e-storia-del-trapianto/https://hpass.tv/capitolo/trapianto-autologo-di-cellule-staminali-emopoietiche/https://hpass.tv/capitolo/trapianto-allogenico-di-cellule-staminali-emopoietiche/https://hpass.tv/capitolo/trapianto-autologo-nei-linfomi-indicazioni-nel-2022/https://hpass.tv/capitolo/trapianto-autologo-nel-mieloma-ancora-utile/https://hpass.tv/capitolo/trapianto-autologo-nella-sclerosi-multipla-standard-of-care/https://hpass.tv/capitolo/regimi-di-condizionamento-esiste-quello-standard/https://hpass.tv/capitolo/la-malattia-acuta-da-rigetto-graft-versus-host-disease-gvhd-la-prevenzione/https://hpass.tv/capitolo/la-malattia-acuta-da-rigetto-graft-versus-host-disease-gvhd-la-terapia/https://hpass.tv/capitolo/linfomi-2022/https://hpass.tv/capitolo/gammopatie-monoclonali/https://hpass.tv/capitolo/disordini-mieloproliferativi-cronici-ph/https://hpass.tv/capitolo/car-t-2022/https://hpass.tv/capitolo/patologie-trombotiche/https://hpass.tv/capitolo/il-sistema-sangue/https://hpass.tv/capitolo/sistema-trasfusionale-italiano/https://hpass.tv/capitolo/sistema-di-emovigilanza-italiano/https://hpass.tv/capitolo/donazione-di-sangue-e-di-emocomponenti/https://hpass.tv/capitolo/plasma-e-medicinali-plasmaderivati/https://hpass.tv/capitolo/sistemi-antigenici-eritrocitari-e-leucocitari/https://hpass.tv/capitolo/sistema-ab0/https://hpass.tv/capitolo/sistema-rh/https://hpass.tv/capitolo/sistema-hla/https://hpass.tv/capitolo/malattia-emolitica-feto-neonatale/https://hpass.tv/capitolo/raccolta-e-impiego-di-cellule-staminali-ematopoietiche/https://hpass.tv/capitolo/ricerca-del-donatore-compatibile-di-cellule-staminali-ematopoietiche/https://hpass.tv/capitolo/aferesi-terapeutica/https://hpass.tv/capitolo/trapianto-di-cellule-staminali-ematopoietiche-ab0-incompatibile/https://hpass.tv/capitolo/anemie-emolitiche-autoimmuni-aspetti-sierologici/https://hpass.tv/capitolo/terapia-trasfusionale/https://hpass.tv/capitolo/terapia-trasfusionale-normativa-vigente/https://hpass.tv/capitolo/indicazioni-alla-terapia-con-concentrati-eritrocitari/https://hpass.tv/capitolo/indicazioni-alla-terapia-con-concentrati-piastrinici/https://hpass.tv/capitolo/effetti-indesiderati-della-trasfusione-di-sangue/https://hpass.tv/capitolo/leucemia-linfoblastica-acuta/https://hpass.tv/capitolo/leucemia-mieloide-acuta/https://hpass.tv/capitolo/patologie-della-coagulazione/https://hpass.tv/capitolo/gestione-dellintolleranza-ai-tki/https://hpass.tv/capitolo/terapia-delle-forme-resistenti-e-ruolo-del-trapianto/https://hpass.tv/capitolo/illustrazione-di-due-casi-clinici-di-leucemia-mieloide-cronica-da-discutere-nei-tavoli-di-lavoro-con-i-discenti-uno-relativo-allapproccio-diagnostico-e-uno-relativo-allapproccio-ter/https://hpass.tv/capitolo/malattie-mieloproliferative-bcr-abl-negative/https://hpass.tv/capitolo/patogenesi-delle-sindromi-mieloproliferative-bcr-abl-negative/https://hpass.tv/capitolo/policitemia-vera-e-trombocitemia-essenziale-diagnosi-clinica-e-scelta-della-terapia-malattie-mieloproliferative-bcr-abl-negative/https://hpass.tv/capitolo/mielofibrosi-diagnosi-clinica-e-scelta-della-terapia-malattie-mieloproliferative-bcr-abl-negative/https://hpass.tv/capitolo/disordini-degli-eosinofili/https://hpass.tv/capitolo/illustrazione-di-due-casi-clinici-uno-relativo-alla-policitemia-vera-e-uno-relativo-alla-mielofibrosi-idiopatica-incentrati-sullapproccio-diagnostico-e-o-terapeutico/https://hpass.tv/capitolo/presentazione-dellesito-della-discussione-dei-casi-clinici-di-policitemia-vera-e-mielofibrosi-idiopatica-da-parte-di-2-specializzandi-scelti-dai-tutor/https://hpass.tv/capitolo/presentazione-dellesito-della-discussione-dei-due-casi-clinici-di-leucemia-mieloide-cronica-da-parte-di-2-specializzandi-scelti-dai-tutor/https://hpass.tv/capitolo/patogenesi/https://hpass.tv/capitolo/terapia/https://hpass.tv/capitolo/neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche-bpdcn/https://hpass.tv/capitolo/the-eha-curriculum-and-eha-offer-to-young-hematologists-present-and-future-directions/https://hpass.tv/capitolo/leucemia-mieloide-cronica-cml/https://hpass.tv/capitolo/leucemia-linfatica-cronica-terapia-di-prima-linea-e-delle-complicanze-autoimmuni/https://hpass.tv/capitolo/illustrazione-del-caso-clinico-di-leucemia-linfatica-cronica-relativo-allapproccio-diagnostico-e-alla-terapia-di-prima-linea/https://hpass.tv/capitolo/illustrazione-del-caso-clinico-di-linfoma-diffuso-a-grandi-cellule-incentrato-sullapproccio-terapeutico/https://hpass.tv/capitolo/illustrazione-del-caso-clinico-di-linfoma-follicolare-incentrato-sullapproccio-terapeutico/https://hpass.tv/capitolo/illustrazione-del-caso-clinico-di-linfoma-mantellare-incentrato-sullapproccio-terapeutico/https://hpass.tv/capitolo/presentazione-dellesito-della-discussione-del-caso-clinico-di-leucemia-linfatica-cronica-relativo-allapproccio-diagnostico-e-alla-terapia-di-prima-linea/https://hpass.tv/capitolo/presentazione-dellesito-della-discussione-del-caso-clinico-di-leucemia-linfatica-cronica-relativo-alla-scelta-terapeutica-nel-paziente-recidivato-refrattario/https://hpass.tv/capitolo/mieloma-multiplo-strategie-terapeutiche-nel-giovane/https://hpass.tv/capitolo/mieloma-multiplo-strategie-terapeutiche-nellanziano/https://hpass.tv/capitolo/terapie-cellulari/https://hpass.tv/capitolo/presentazione-dellesito-della-discussione-del-caso-clinico-di-linfoma-diffuso-a-grandi-cellule-incentrato-sullapproccio-terapeutico/https://hpass.tv/capitolo/presentazione-dellesito-della-discussione-del-caso-clinico-di-linfoma-mantellare-incentrato-sullapproccio-terapeutico/https://hpass.tv/capitolo/presentazione-dellesito-della-discussione-del-caso-clinico-di-linfoma-follicolare-incentrato-sullapproccio-terapeutico/https://hpass.tv/capitolo/car-t-e-trapianti-nelle-leucemie-acute-linfoblastiche-lal/https://hpass.tv/capitolo/immunofenotipo-delle-lal-inquadramento-delle-leucemie-acute-linfoblastiche-lal/https://hpass.tv/capitolo/classificazione-e-genetica-delle-lal/https://hpass.tv/capitolo/trattamento-delle-lal-ph-terapia-delle-leucemie-acute-linfoblastiche-lal/https://hpass.tv/capitolo/trattamento-delle-lal-ph-terapia-delle-leucemie-acute-linfoblastiche-lal-2/https://hpass.tv/capitolo/lal-ph-like/https://hpass.tv/capitolo/car-t-cells-indicazioni-procedure-e-complicanze/https://hpass.tv/capitolo/trapianto-allogenico-nelle-lal-indicazioni-procedure-e-complicanze/https://hpass.tv/capitolo/casi-clinici/https://hpass.tv/capitolo/classificazione-delle-lam/https://hpass.tv/capitolo/terapia-di-induzione-e-consolidamento-delle-lam-del-giovane-e-dellanziano/https://hpass.tv/capitolo/trapianto-allogenico-indicazioni-procedure-e-complicanze/https://hpass.tv/capitolo/caso-clinico-di-leucemia-acuta-mieloide-relativo-a-lam-con-traslocazioni-specifiche/https://hpass.tv/capitolo/caso-clinico-di-leucemia-acuta-mieloide-relativo-alla-leucemia-a-promielociti/https://hpass.tv/capitolo/caso-clinico-di-leucemia-acuta-mieloide-relativo-alle-leucemie-post-sindrome-mielodisplastica/https://hpass.tv/capitolo/approccio-diagnostico-alle-anemie-emolitiche-e-citopenie-immuno-mediate/https://hpass.tv/capitolo/anemie-immuno-emolitiche-da-anticorpi-caldi/https://hpass.tv/capitolo/anemie-diseritropoietiche-congenite/https://hpass.tv/capitolo/cold-agglutinin-disease-e-altre-malattie-complemento-mediate/https://hpass.tv/capitolo/avanzamenti-sul-fronte-della-terapia-genica-nelle-anemie-ereditarie/https://hpass.tv/capitolo/covid-19-nelle-neoplasie-ematologiche-highlights/https://hpass.tv/capitolo/malattia-minima-residua/https://hpass.tv/capitolo/impatto-della-malattia-minima-residua-nelle-leucemie-acute-linfoblastiche/https://hpass.tv/capitolo/impatto-della-malattia-minima-residua-nelle-leucemie-acute-mieloidi/https://hpass.tv/capitolo/ruolo-del-laboratorio-nello-studio-della-coagulazione/https://hpass.tv/capitolo/biologia-molecolare-2/https://hpass.tv/capitolo/leucemie-mieloidi-acute/https://hpass.tv/capitolo/disordini-mieloproliferativi-cronici/https://hpass.tv/capitolo/leucemie-acute-linfoblastiche-lal-biologia-molecolare-2/https://hpass.tv/capitolo/leucemia-linfatica-cronica-llc-biologia-molecolare-2/https://hpass.tv/capitolo/coagulazione-morfologia-immunofenotipo-e-istopatologia/https://hpass.tv/capitolo/morfologia-quadri-normali-ed-esempi-tipici-di-malattie-del-sangue/https://hpass.tv/capitolo/ruolo-dellistopatologia-nella-diagnosi-delle-emopatie/https://hpass.tv/capitolo/immunofenotipo-delle-leucemie-acute/https://hpass.tv/capitolo/disordini-linfoproliferativi-cronici-cll-b-pll-hcl-lgl-t-pll/https://hpass.tv/capitolo/mieloma-inclusi-car-t-e-bispecifici/https://hpass.tv/capitolo/linfomi-indolenti-inclusi-car-t-e-bispecifici/https://hpass.tv/capitolo/linfoma-mantellare-e-diffuso-a-grandi-cellule-inclusi-car-t-e-bispecifici/https://hpass.tv/capitolo/leucemia-acuta-linfoblastica-inclusi-car-t-e-bispecifici/https://hpass.tv/capitolo/sindromi-mielodisplastiche-highlights/https://hpass.tv/capitolo/disordini-acquisiti-della-coagulazione/https://hpass.tv/capitolo/disordini-congeniti-dellemostasi/https://hpass.tv/capitolo/disordini-piastrinici-acquisiti-trombocitopenie-microangiopatie/https://hpass.tv/capitolo/disordini-trombotici/https://hpass.tv/capitolo/trombocitopenia-immune-disordini-piastrinici-acquisiti-trombocitopenie-microangiopatie/https://hpass.tv/capitolo/microangiopatie-trombotiche-focus-sulla-ttp/https://hpass.tv/capitolo/trombocitopenia-indotta-da-eparina-e-vitt/https://hpass.tv/capitolo/trombocitopenie-in-gravidanza/https://hpass.tv/capitolo/emorragia-massiva-in-ostetricia-trauma-chirurgia-disordini-acquisiti-della-coagulazione/https://hpass.tv/capitolo/complicanze-emorragiche-in-corso-di-terapia-anticoagulante-disordini-acquisiti-della-coagulazione/https://hpass.tv/capitolo/rischio-emorragico-trombotico-nelle-epatopatie/https://hpass.tv/capitolo/coagulazione-intravascolare-disseminata-disordini-acquisiti-della-coagulazione/https://hpass.tv/capitolo/disordini-emorragici-acquisiti-nelladulto-focus-su-emofilia-acquisita-sindrome-di-von-willebrand-acquisita-e-piastrinopatie-acquisite/https://hpass.tv/capitolo/emofilia-vecchie-problematiche-e-innovazione-terapeutica/https://hpass.tv/capitolo/malattia-di-willebrand-focus-sulle-nuove-linee-guida-di-diagnosi-e-trattamento/https://hpass.tv/capitolo/come-e-cambiato-lapproccio-terapeutico-dei-pups-previous-untreated-patients-e-la-gestione-degli-inibitori-ai-tempi-della-terapia-non-sostitutiva/https://hpass.tv/capitolo/terapia-genica-in-emofilia-risultati-dagli-studi-clinici-ed-esperienze-real-life-pro-e-contro/https://hpass.tv/capitolo/diagnosi-e-trattamento-del-tromboembolismo-venoso/https://hpass.tv/capitolo/disordini-coagulativi-rari-disordini-congeniti-dellemostasi/https://hpass.tv/capitolo/disordini-piastrinici-congeniti-disordini-trombotici/https://hpass.tv/capitolo/trombofilia-congenita-ed-acquisita-disordini-trombotici/https://hpass.tv/capitolo/profilassi-e-terapia-del-tromboembolismo-venoso-nei-pazienti-con-cancro-disordini-trombotici-2/https://hpass.tv/capitolo/profilassi-e-terapia-del-tromboembolismo-venoso-in-gravidanza-disordini-trombotici/https://hpass.tv/capitolo/trombosi-in-eta-pediatrica/https://hpass.tv/capitolo/sindrome-da-anticorpi-antifosfolipidi-nuova-classificazione-e-trattamento/